catechin has been researched along with Mucositis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altavilla, D; Irrera, N; Mannino, F; Minutoli, L; Oteri, G; Pallio, G; Picciolo, G; Squadrito, F; Vaccaro, M | 1 |
| Jia, L; Li, X; Mei, H; Meng, X; Xing, L; Yu, J; Zhao, H; Zhao, X; Zhu, W | 1 |
1 trial(s) available for catechin and Mucositis
| Article | Year |
|---|---|
Epigallocatechin-3-gallate mouthwash protects mucosa from radiation-induced mucositis in head and neck cancer patients: a prospective, non-randomised, phase 1 trial.
Topics: Adult; Aged; Catechin; Chemoradiotherapy; Head and Neck Neoplasms; Humans; Maximum Tolerated Dose; Middle Aged; Mouth Mucosa; Mouthwashes; Mucositis; Prospective Studies; Radiation Injuries; Young Adult | 2020 |
1 other study(ies) available for catechin and Mucositis
| Article | Year |
|---|---|
Reduction of oxidative stress blunts the NLRP3 inflammatory cascade in LPS stimulated human gingival fibroblasts and oral mucosal epithelial cells.
Topics: Catechin; Drug Combinations; Epithelial Cells; Fibroblasts; Gingiva; Humans; Inflammasomes; Lipopolysaccharides; Mouth Mucosa; Mucositis; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress | 2022 |